Literature DB >> 33411141

Anti-vinculin autoantibodies in systemic sclerosis: a step toward a novel biomarker?

Brittany L Adler1, Zsuzsanna McMahan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33411141      PMCID： PMC7897257          DOI： 10.1007/s10067-020-05533-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  16 in total

1.  A technical review and clinical assessment of the wireless motility capsule.

Authors:  Richard J Saad; William L Hasler
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

Review 2.  A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract.

Authors:  K M Sanders
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

3.  Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms.

Authors:  E S Bonapace; A H Maurer; S Davidoff; B Krevsky; R S Fisher; H P Parkman
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  Immunization with cytolethal distending toxin B produces autoantibodies to vinculin and small bowel bacterial changes in a rat model of postinfectious irritable bowel syndrome.

Authors:  Walter Morales; Konstantinos Triantafyllou; Gonzalo Parodi; Stacy Weitsman; Sung Chul Park; Ali Rezaie; Nipaporn Pichetshote; Eugenia Lin; Mark Pimentel
Journal:  Neurogastroenterol Motil       Date:  2020-05-21       Impact factor: 3.598

5.  Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.

Authors:  Ali Rezaie; Sung Chul Park; Walter Morales; Emily Marsh; Anthony Lembo; Jae Hak Kim; Stacy Weitsman; Kathleen S Chua; Gillian M Barlow; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2017-04-27       Impact factor: 3.199

6.  Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility.

Authors:  Y Kawaguchi; Y Nakamura; I Matsumoto; E Nishimagi; T Satoh; M Kuwana; T Sumida; M Hara
Journal:  Ann Rheum Dis       Date:  2008-09-01       Impact factor: 19.103

7.  Lactose malabsorption in systemic sclerosis.

Authors:  I Marie; A-M Leroi; G Gourcerol; H Levesque; J-F Menard; P Ducrotte
Journal:  Aliment Pharmacol Ther       Date:  2016-09-28       Impact factor: 8.171

8.  Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.

Authors:  Mark Pimentel; Walter Morales; Ali Rezaie; Emily Marsh; Anthony Lembo; James Mirocha; Daniel A Leffler; Zachary Marsh; Stacy Weitsman; Kathleen S Chua; Gillian M Barlow; Enoch Bortey; William Forbes; Allen Yu; Christopher Chang
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

9.  Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts.

Authors:  Elizabeth R Volkmann; Anna-Maria Hoffmann-Vold; Yu-Ling Chang; Jonathan P Jacobs; Kirsten Tillisch; Emeran A Mayer; Philip J Clements; Johannes R Hov; Martin Kummen; Øyvind Midtvedt; Venu Lagishetty; Lin Chang; Jennifer S Labus; Øyvind Molberg; Jonathan Braun
Journal:  BMJ Open Gastroenterol       Date:  2017-04-01

10.  Association between interstitial cells of Cajal and anti-vinculin antibody in human stomach.

Authors:  Ji Hyun Kim; Seung-Joo Nam; Sung Chul Park; Sang Hoon Lee; Tae Suk Kim; Minjong Lee; Jin Myung Park; Dae Hee Choi; Chang Don Kang; Sung Joon Lee; Young Joon Ryu; Kyungyul Lee; So Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2020-02-20       Impact factor: 2.016
View more
  1 in total

1.  Colostrum-Induced Temporary Changes in the Expression of Proteins Regulating the Epithelial Barrier Function in the Intestine.

Authors:  Sylwia Rzeszotek; Grzegorz Trybek; Maciej Tarnowski; Karol Serwin; Aleksandra Jaroń; Gabriela Schneider; Agnieszka Kolasa; Barbara Wiszniewska
Journal:  Foods       Date:  2022-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.